ArticleMaterials today. Bio2026
Redox-responsive peptide folding enables intracellular self-assembly and controlled nucleic acid release.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracellular peptide self-assembly provides a powerful strategy for spatiotemporal control of biomolecular interactions, yet most existing systems rely on irreversible triggers, limiting dynamic regulation. Herein, we report a redox-responsive amphiphilic peptide with a strategically positioned intramolecular disulfide bond, enabling reversible switching between a disordered coil and a β-hairpin conformation. In oxidized state, the peptide efficiently complexes with nucleic acids and penetrates cells. Intracellular glutathione reduction cleaves the disulfide, inducing β-hairpin folding, which drives supramolecular self-assembly into nanofibrils and concomitantly releases nucleic acid cargo. This three-step, reduction-responsive, assembly and release (RAR) mechanism achieves efficient, spatiotemporally controlled intracellular delivery. Structural, biophysical, and imaging analyses confirm the redox-triggered conformational transition, intracellular assembly, and cargo dissociation. This reversible and programmable platform establishes a generalizable design principle for stimulus-responsive biomaterials and nucleic acid therapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.